Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata-MedSci.cn

Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata

Mostaghimi, A; Mesinkovska, NA; Senna, MM; King, B; Hamilton, C; Cassella, J

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023; 89 (3): AB164

科室
- - 订阅+
  - 更多科室
工具
服务